AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AXIM Biotechnologies's revenue for the twelve months ending Jun 30, 2024 was $92.90K, up 254.6% year over year. For fiscal 2023 it was $39.52K, up 345.3% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $799.48K in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $39.52K | +345.3% |
| FY2022 | Dec 31, 2022 | $8.88K | -85.3% |
| FY2021 | Dec 31, 2021 | $60.46K | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $799.48K | +308.7% |
| FY2018 | Dec 31, 2018 | $195.61K | +311.2% |
| FY2017 | Dec 31, 2017 | $47.57K | +1.1% |
| FY2016 | Dec 31, 2016 | $47.06K | -4.2% |
| FY2015 | Dec 31, 2015 | $49.14K | – |
| FY2014 | Dec 31, 2014 | $0 | -100.0% |
| FY2013 | Dec 31, 2013 | $21.67K | -50.0% |
| FY2012 | Dec 31, 2012 | $43.33K | +333.3% |
| FY2011 | Dec 31, 2011 | $10.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $17.48K | +76.0% |
| Q1 FY2024 | Mar 31, 2024 | $52.98K | +616.2% |
| Q4 FY2023 | Dec 31, 2023 | $12.86K | +70.1% |
| Q3 FY2023 | Sep 30, 2023 | $9.58K | +629.1% |
| Q2 FY2023 | Jun 30, 2023 | $9.93K | – |
| Q1 FY2023 | Mar 31, 2023 | $7.40K | – |
| Q4 FY2022 | Dec 31, 2022 | $7.56K | +57.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.31K | -83.8% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021 | Dec 31, 2021 | $4.81K | – |
| Q3 FY2021 | Sep 30, 2021 | $8.13K | – |
| Q2 FY2021 | Jun 30, 2021 | $14.88K | – |
| Q1 FY2021 | Mar 31, 2021 | $32.65K | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $799.48K | +378.8% |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $17.06K | +19.7% |
| Q4 FY2018 | Dec 31, 2018 | $166.97K | +980.2% |
| Q3 FY2018 | Sep 30, 2018 | $6.22K | -36.2% |
| Q2 FY2018 | Jun 30, 2018 | $8.17K | +118.7% |
| Q1 FY2018 | Mar 31, 2018 | $14.25K | -23.5% |
| Q4 FY2017 | Dec 31, 2017 | $15.46K | +26.6% |
| Q3 FY2017 | Sep 30, 2017 | $9.76K | +1.6% |
| Q2 FY2017 | Jun 30, 2017 | $3.74K | -66.7% |
| Q1 FY2017 | Mar 31, 2017 | $18.62K | +33.0% |
| Q4 FY2016 | Dec 31, 2016 | $12.21K | -20.8% |
| Q3 FY2016 | Sep 30, 2016 | $9.60K | -55.6% |
| Q2 FY2016 | Jun 30, 2016 | $11.24K | -7.2% |
| Q1 FY2016 | Mar 31, 2016 | $14.01K | – |
| Q4 FY2015 | Dec 31, 2015 | $15.42K | – |
| Q3 FY2015 | Sep 30, 2015 | $21.61K | – |
| Q2 FY2015 | Jun 30, 2015 | $12.11K | – |
| Q1 FY2015 | Mar 31, 2015 | $0 | – |
| Q4 FY2014 | Dec 31, 2014 | $0 | – |
| Q3 FY2014 | Sep 30, 2014 | $0 | – |
See a number that looks wrong?